Search Results for 'Metastatic-Nsclc'

Metastatic-Nsclc published presentations and documents on DocSlides.

Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
by debby-jeon
Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...
Consensus or Controversy?  
Consensus or Controversy?  
by okelly
Addressing Practical Clinical Questions Across the...
SW GLH services for NSCLC – An update
SW GLH services for NSCLC – An update
by everly
Professor Rachel Butler. The genomic complexity of...
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
by sherrill-nordquist
The Coming Paradigm Shift. Faculty. Suresh S. Ram...
Antiangiogenic   Agents in Advanced NSCLC
Antiangiogenic Agents in Advanced NSCLC
by ellena-manuel
Jared Weiss, MD . Assistant . Professor of Medici...
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
by stefany-barnette
Renato G. Martins, MD, MPH. Medical Director, Tho...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by chaptoe
proceedings from the live CME event and may includ...
Please note, these are the
Please note, these are the
by disclaimercanon
actual. . video-recorded proceedings from the . l...
Paradigm Shift in the Management of  Metastatic Castration-Sensitive                 Prostate Cance
Paradigm Shift in the Management of Metastatic Castration-Sensitive Prostate Cance
by luna
m. CSPC). 1. Neal Shore, MD, FACS. Carolina Urolog...
Treatment in Advanced  Non-Small Cell Lung Cancer
Treatment in Advanced Non-Small Cell Lung Cancer
by oconnor
. 5. th. most commonly diagnosed cancer in Austra...
Multidisciplinary approach         to lung cancer
Multidisciplinary approach to lung cancer
by elena
Kamil Konopka. Department of Oncology, University ...
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
NSCLC: Epidemiology  and disease characteristics
NSCLC: Epidemiology and disease characteristics
by scarlett
NSCLC, non-small cell lung cancer.. Lung cancer in...
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
by southan
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...
The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature
The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature
by stefany-barnette
The Cancer genome atlas (TCGA) and the search for...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
by pasty-toler
This program will include a discussion of off-lab...
Comparision
Comparision
by jane-oiler
of the expression of . 17-beta-hydroxysteroid . ...
James Yang,
James Yang,
by pasty-toler
MD. The Evolving Treatment Landscape in NSCLC: Co...
NSCLC with high PD-L1 expression on tumor cells or tumor-in
NSCLC with high PD-L1 expression on tumor cells or tumor-in
by test
Intervista a Federico . Cappuzzo. Background:. P...
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
by ellena-manuel
Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...
Michael
Michael
by luanne-stotts
Brada. . Torino. . 6 March 2015. Perspectives...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
David R.
David R.
by alida-meadow
Gandara. , MD. University of California, Davis . ...
Thierry
Thierry
by cheryl-pisano
Le Chevalier, . MD. The Role of Translational Res...
Striving for Consensus on the
Striving for Consensus on the
by samantha
Optimal Management of Metastatic . Non-Small Cell ...
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
by olivia-moreira
Low TPS High TPS TPS = PD-L1 tumor proportion sco...
Completeness Charlton Aaron Bossler Elizabeth Chrischilles
Completeness Charlton Aaron Bossler Elizabeth Chrischilles
by lionel
A comparison of data sources at an academic medica...
Incorporating Immunotherapy in management of HNSCC
Incorporating Immunotherapy in management of HNSCC
by candy
ندوة أورام الرأس . و. العنق. ...
Metastatic  Glucagonoma  Presenting with Weight Loss and
Metastatic Glucagonoma Presenting with Weight Loss and
by rodriguez
Necrolytic. Migratory Erythema. 胃腸科 林榮é...
Pashtoon Kasi, MD, MS Director, Colon Cancer Research
Pashtoon Kasi, MD, MS Director, Colon Cancer Research
by heavin
Director, Precision Medicine Research for Liquid B...
Systemic Therapy of Breast Cancer
Systemic Therapy of Breast Cancer
by abigail
Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhut...
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
NASPCC: Chemotherapy Options for Advanced Prostate Cancer
by ceila
Jeanny B. Aragon-Ching, M.D., F.A.C.P.. Clinical P...
Trends in survival from metastatic lung cancer in California, 1990-2014
Trends in survival from metastatic lung cancer in California, 1990-2014
by thomas
. Rosemary D. Cress, . DrPH. Amy K. Klapheke, MPH,...
Advanced Breast Cancer 31 year old female px  severe pain right UL ‘burning’ pain
Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain
by margaret
Background of lower back pain for 3/12 . No past ...
Nuclear Medicine procedures in prostate cancer: from diagnosis to treatment
Nuclear Medicine procedures in prostate cancer: from diagnosis to treatment
by joy
Francesco GIAMMARILE. « . Aut tace aut loquere m...
Prostate cancer: To screen or not to screen
Prostate cancer: To screen or not to screen
by evans
–. To treat . or not to treat. Dr Oliver Klein â...